Literature DB >> 27789518

High prevalence of insomnia and hypnotic use in patients visiting their general practitioner.

Bjørn Bjorvatn1,2, Eivind Meland3, Elisabeth Flo3, Thomas Mildestvedt3.   

Abstract

BACKGROUND: Sleep problems are common in the general population, but there are few prevalence studies among patients visiting their GP. Since sleep problems frequently co-occur with existing psychological and somatic conditions, the prevalence is likely to be higher in patients visiting their GPs compared to the prevalence in the general population.
OBJECTIVES: To estimate the prevalence of insomnia [based on the Diagnostic and Statistical Manual for Mental disorders (DSM)-version IV] and hypnotic use among patients in general practice and to evaluate whether the prevalence depended on sex and age.
METHODS: Questionnaire data were collected by 66 medical students while deployed in different general practices during their last year of school. A total of 1346 (response rate 74%) consecutive and unselected patients visiting their GPs answered the validated Bergen Insomnia Scale (BIS) and single questions on self-reported sleep problems and hypnotic use.
RESULTS: The prevalence of insomnia according to BIS was 53.6%. Sleep problems (based on the single question) were self-reported by 55.8%, with 18.0% reporting to experience sleep problems a lot/very much. Hypnotic use was reported by 16.2% (daily use by 5.5%). Insomnia and hypnotic use were all more prevalent in females compared with males. Hypnotic use increased with age, whereas the prevalence of insomnia was highest in the younger age groups.
CONCLUSIONS: Insomnia and hypnotic use were very prevalent among patients visiting their GPs. As insomnia can be effectively treated, we maintain that the diagnosis has a high pay-off and should earn greater awareness in GP's diagnostic evaluation and management.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  GP; family practice; general practice; insomnia; sleep.

Mesh:

Substances:

Year:  2016        PMID: 27789518     DOI: 10.1093/fampra/cmw107

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  17 in total

1.  An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019.

Authors:  Prasad S Nishtala; Te-Yuan Chyou
Journal:  Drugs Aging       Date:  2022-07-13       Impact factor: 4.271

2.  Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior.

Authors:  Edouard-Jules Laforgue; Marion Istvan; Benoit Schreck; Marie Mainguy; Pascale Jolliet; Marie Grall-Bronnec; Caroline Victorri-Vigneau
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

Review 3.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19

4.  Therapeutic Effect of Berberine on Insomnia Rats by ErbB Signaling Pathway.

Authors:  Qingquan Wang; Xiaojuan Ren; Xingping Zhang; Guanying Wang; Hongxia Xu; Ning Deng; Tao Liu; Zhipeng Peng
Journal:  Med Sci Monit       Date:  2020-07-05

5.  Evaluation of the age-related and gender-related differences in patients with primary insomnia by fractional amplitude of low-frequency fluctuation: A resting-state functional magnetic resonance imaging study.

Authors:  Yu-Kai Wang; Xiao-Hua Shi; Ying-Ying Wang; Xin Zhang; Hong-Yu Liu; Xin-Tong Wang; Jing Mang; Zhong-Xin Xu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  Haunted by the past: old emotions remain salient in insomnia disorder.

Authors:  Rick Wassing; Frans Schalkwijk; Oti Lakbila-Kamal; Jennifer R Ramautar; Diederick Stoffers; Henri J M M Mutsaerts; Lucia M Talamini; Eus J W Van Someren
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

7.  Albizia julibrissin Ameliorates Memory Loss Induced by Insomnia in Drosophila.

Authors:  Jui-Shu Chang; Hsin-Ping Liu; Jack Cheng; Chao-Jung Chen; Su-Lun Hwang; Chi-Chuan Tseng; Lee-Fen Hsu; Wei-Yong Lin
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

Review 8.  Clinician and patient barriers to the recognition of insomnia in family practice: a narrative summary of reported literature analysed using the theoretical domains framework.

Authors:  Rowan P Ogeil; Samantha P Chakraborty; Alan C Young; Dan I Lubman
Journal:  BMC Fam Pract       Date:  2020-01-04       Impact factor: 2.497

9.  Self-reported sleeplessness in 12,655 persons living in the north of Norway: The Tromsø Study.

Authors:  Arne Fetveit; Jørund Straand; Bjørn Bjorvatn; Espen Saxhaug Kristoffersen
Journal:  Sleep Sci       Date:  2019 Jul-Sep

10.  Do older people know why they take benzodiazepines? A national French cross-sectional survey of long-term consumers.

Authors:  Edouard-Jules Laforgue; Alexandra Jobert; Morgane Rousselet; Marie Grall-Bronnec; Pascale Jolliet; Fanny Feuillet; Caroline Victorri-Vigneau
Journal:  Int J Geriatr Psychiatry       Date:  2020-04-21       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.